Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,171,000 | 3,123,000 | 2,158,000 | 5,518,000 | 7,894,000 |
| Depreciation Amortization | 3,467,000 | 1,736,000 | 6,290,000 | 4,620,000 | 3,060,000 |
| Income taxes - deferred | -1,224,000 | -441,000 | -3,442,000 | -1,584,000 | -1,471,000 |
| Accounts receivable | N/A | N/A | 347,000 | N/A | N/A |
| Other Working Capital | -6,871,000 | -3,336,000 | -2,172,000 | -10,622,000 | -9,423,000 |
| Other Operating Activity | 766,000 | 8,000 | 5,519,000 | 5,528,000 | -56,000 |
| Operating Cash Flow | $-691,000 | $1,090,000 | $8,700,000 | $3,460,000 | $4,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,996,000 | -1,326,000 | 13,464,000 | -18,222,000 | -19,629,000 |
| PPE Investments | -1,341,000 | -704,000 | -3,907,000 | -2,863,000 | -2,053,000 |
| Net Acquisitions | N/A | N/A | -43,430,000 | -25,000 | -25,000 |
| Purchase Of Investment | -108,000 | -35,000 | -204,000 | -166,000 | -92,000 |
| Sale Of Investment | 3,803,000 | 3,796,000 | 1,979,000 | 189,000 | 172,000 |
| Other Investing Activity | -18,000 | 1,000 | -180,000 | -195,000 | -543,000 |
| Investing Cash Flow | $6,332,000 | $1,732,000 | $-32,278,000 | $-21,282,000 | $-22,170,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,913,000 | -595,000 | 7,686,000 | -92,000 | 36,000 |
| Debt Issued | 0 | N/A | 30,831,000 | 30,831,000 | 30,831,000 |
| Debt Repayment | -2,250,000 | -1,250,000 | -2,569,000 | -2,569,000 | -1,269,000 |
| Dividend Paid | -4,752,000 | -2,372,000 | -9,247,000 | -6,932,000 | -4,618,000 |
| Other Financing Activity | -5,301,000 | -714,000 | -635,000 | -614,000 | -577,000 |
| Financing Cash Flow | $-7,390,000 | $-4,931,000 | $26,066,000 | $20,624,000 | $24,403,000 |
| Exchange Rate Effect | -46,000 | -28,000 | -40,000 | -39,000 | -7,000 |
| Beginning Cash Position | 2,917,000 | 2,917,000 | 468,000 | 468,000 | 468,000 |
| End Cash Position | 1,123,000 | 780,000 | 2,917,000 | 3,233,000 | 2,698,000 |
| Net Cash Flow | $-1,794,000 | $-2,137,000 | $2,448,000 | $2,764,000 | $2,229,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -691,000 | 1,090,000 | 8,700,000 | 3,460,000 | 4,000 |
| Capital Expenditure | -1,341,000 | -704,000 | -3,907,000 | -2,863,000 | -2,053,000 |
| Free Cash Flow | -2,032,000 | 386,000 | 4,793,000 | 597,000 | -2,049,000 |